Data-driven research for an investment raise, taking the hours of work off the founding team.
Proof
Case studies: where our clients' growth came from
Term sheets signed, acquisitions closed, partners found and capital raised, for startups, mid-sized companies, industry leaders and investors. Each case says what the client faced, what we did and what changed, as plainly as they allow.
Growth: new products, new markets, new partners
Other firms would file these under innovation. For our clients, each one was a line in the growth plan that needed evidence behind it.
Case file 01 · Growth Strategy
XTEND: existing technology into new markets, $20M raised
Later exited.
The challenge
XTEND wanted to take technology it already had into new markets, and needed investors to believe in the plan.
What we did
We mapped the new markets and built the growth case around them, including an IP position investors could see would hold.
The result
47 protectable innovations identified in the new markets, supporting a $20M Series A. XTEND later exited.
Why it matters
Market development, the second box on the growth grid, funded by the investors it needed to convince.
Case file 02 · Growth Strategy
Blink: US market entry with a seven-figure partner
From Shamir Optiks.
The challenge
Blink needed to enter the US market, and a partner to help it do so.
What we did
We built the US market-entry plan and the IP strategy behind it, then supported the partnership that followed.
The result
A seven-figure collaboration and investment from Shamir Optiks.
Why it matters
A new market entered with a partner and capital behind it, not alone.
Case file 03 · Growth Strategy · Client not named, available under NDA
From customer interviews to a signed term sheet
Started with customers, not a market report.
The challenge
An industrial technology company believed one of its technologies could serve a new application, but had no evidence customers would pay for it.
What we did
We started with customers, not a market report. Interviews tested whether the application solved a problem buyers would pay to fix. When the evidence held, we carried the work through the deal rather than handing over a recommendation.
The result
A signed term sheet, a field trial to prove the technology in use, and a grant strategy to help fund the next stage.
Why it matters
The full method, from the first interview to a signature.
Case file 04 · Growth Strategy · Corporate development
BHP: twelve R&D programs, weighed and partnered
Scored on one rubric, so a mining-automation program could be compared against a cybersecurity program on the same terms.
The challenge
BHP's R&D effort ran across international groups with different mandates and no shared way to compare them. Leadership judged every project on the same four questions — how mature the technology is, how big the business impact could be, how far competitors have already moved, and whether BHP held any IP edge — but had no consistent way to score a project against them, and no consistent way to decide whether to buy, build, partner or invest. Budget sat unallocated because nobody could show, with evidence, which project was worth the spend.
What we did
We built one scoring rubric that could be applied to any technology, so a mining-automation program and a cybersecurity program could be compared on the same terms. Every assessment scored four areas — technology, intellectual property, market and competitive position — on the same five-point scale, and every score carried its own confidence rating, so a finding drawn from a patent filing or an annual report counted differently from one drawn from a press release. For the programs worth pursuing, we identified strategic partners and negotiated collaboration and field-trial agreements for technology access.
The result
Twelve programs assessed and scored. Across the programs where we scored the window of opportunity, BHP was leading the market in none of them — and held a real window to lead, if it acted, in five. In the rest, the honest finding was that BHP's best case was to catch the market rather than lead it: a signal to buy or partner rather than build.
Why it matters
That split is the finding. Most of the bets were still winnable, but only inside a window that was closing — which is exactly the evidence a budget conversation needs. More good ideas than people is the most common growth problem we see, and this is how it gets solved at scale.
Case file 05 · Growth Strategy · IP Strategy & Management
GET Trakka: IP strategy that turned into two exits
One portfolio, split across two companies.
The challenge
GET Trakka needed a structure that could support two businesses and a sale of each.
What we did
We designed the structure behind the growth: a portfolio built and split across two companies, with licensing between them.
The result
Both businesses were acquired within days of each other in late 2020. GET Trakka was acquired by CR on 30 October 2020 (announcement), and the MILL Trakka business by Molycop on 2 November 2020 (announcement).
The team at Rapid Alpha delivered immediate returns on investment for us. They not only help us increase the value of our business through a comprehensive and affordable IP strategy, but they also help us take steps to negotiate from a position of strength.
Case file 06 · Due Diligence
Boutique Venture Partners: technology diligence for a venture investor
The challenge
A venture fund needed an independent, evidence-based view of the technology and competitive position of the companies it was considering, without building a research team of its own.
What we did
We blended a core understanding of complex technologies and intellectual property to support Boutique in navigating investments in startups like miRecule and Genalyte. We assessed each company's competitive advantage against the alternatives, scored it on a consistent scale, and reported the result to the fund's investment team.
The result
Every opportunity was assessed against the same criteria, so the fund could compare companies on the same terms before committing capital.
Case file 08 · Corporate development · IP Strategy & Management
Boeing Research & Technology: 10,000 patents turned into a licensing pipeline
A patent portfolio scanned, matched to partners and turned into introductions.
The challenge
Boeing Research & Technology held a large patent portfolio built to protect its own products. Much of it had commercial value outside aerospace. But no one had the time to read 10,000 patents and applications, match them to markets and decide which companies to approach. The licensing team needed a business case, not another list of patents.
What we did
We became the research engine behind Boeing’s licensing team. Over nine months, we scanned every patent and pending application, using public information to find where each technology fit a specific prospective partner. We built a technology catalog and an interactive dashboard that put the technology, the market and the fit in one view. We identified the right people to contact. Then we equipped Boeing’s licensing executives with materials for every phase, from first conversation to deal terms to integration after close. Boeing’s teams stayed on the relationships while we handled the analysis.
The result
The first opportunities reached the market within 15 days, using technologies Boeing already held, extended to new uses. Boeing’s licensing executives were introduced to commercialization partners, with materials ready for every stage of the deal.
Why it matters
Licensing went from a stack of patents to a repeatable pipeline, and Boeing’s experts spent their time in the field instead of on analyst work.
Case file 08 · Growth Strategy
South32: the scoring built, then handed over
Simplified until their own analysts could apply it consistently, not until it looked thorough.
The challenge
South32 had stood up a new internal team to find emerging technologies worth backing, and no consistent way to judge what arrived. Ideas came in from across the business in whatever shape the person writing them chose. Vendors pitched unsolicited. Nothing could be compared against anything else, so nothing could be confidently funded.
What we did
A scoring rubric is only useful if ideas arrive in a shape it can score, so we built the intake as well as the scoring: a problem-statement form, a fuller capture document behind it, a parallel form so inbound vendor pitches were judged on the same terms as internal ideas, and a business value framework that weighted the score, so a technically exciting idea with no path to value could not outrank a modest one with a clear path.
The first rubric ran to 21 factors. We tested it with South32's own analysts, found it too heavy to apply consistently at the volume they needed, and cut it to 16 — four per quadrant, each with plain scoring language and a worked example.
The result
Four documented procedures and a rubric their own team could run, each closed out with a walkthrough and a tutorial for the wider group rather than a file sent over. South32 ran the intake themselves; we scored what came out.
Why it matters
The rubric wasn't handed down finished. It was built, tested against the people who had to use it, and cut back until it worked — which is what installing a capability looks like, as opposed to delivering a report about one.
Case file 09 · Growth Strategy · Due Diligence
NCS Multistage: a go/no-go in four days
And a second phase that was only chargeable if the first one said go.
The challenge
NCS Multistage had already put real money into researching an emerging separation technology, and faced the question that money raises: is this close enough to commercial to keep funding, or should the budget go somewhere with a better chance. Getting that wrong in either direction is expensive — walk away from something viable, or keep paying for something that isn't.
What we did
We agreed the decision rule before doing any research, so the answer couldn't be argued with afterwards. If the technology readiness levels came in low, the evidence would say not commercially viable in the near term. If they came in high, or we found products already operating at full working scale, it would say the opposite.
Then we went looking: patent literature, paid startup databases, peer-reviewed and industry publications, and the government grants being awarded in the field — because who is funding what is often the earliest signal of where a technology really sits.
The result
A documented viability call in four business days for $2,700, with the evidence behind it. A second phase bringing in subject-matter experts was scoped and priced at $2,200, to run only if the first phase found the technology viable — not started and not invoiced otherwise.
Why it matters
This is the smallest shape our work comes in: one question, a decision rule agreed up front, and a fee that is trivial against the research budget it was protecting. Stage-gating isn't a pricing gimmick — the second phase genuinely doesn't happen if the first one says stop.
Case file 10 · Due Diligence · Client not named, available under NDA
A buyer who wanted the answer before the bid, not after
No report. A thirty-minute call, in time to change the bid.
The challenge
A private equity buyer was weeks from a final bid in a competitive process. The target's product line, and a reformulation it planned to launch the following quarter, both sat in a crowded patent space held by much larger companies. If something in there was deal-blocking, they needed to know before bidding, not during post-close integration. What they did not need was a document.
What we did
We ran two freedom-to-operate scans in parallel: one across the existing product, its manufacturing process and its packaging; one across the planned reformulation. We concentrated on filings from the last six to seven years, where the activity was densest, with a lighter sweep back two decades, and we looked specifically for the scenarios that kill deals — elements that read directly onto a major competitor's patent, techniques already claimed and enforced internationally, and patents currently in litigation.
The deliverable was a thirty-minute call: all clear, monitoring needed, or high risk, with the specific patents of concern and the questions worth putting to the management team. They had asked for speed over paperwork, so we gave them speed.
The result
An evidence-backed read on deal-blocking risk inside the bid window, for a fixed $24,750 — with an explicit off-ramp: if a fatal issue surfaced, the engagement stopped there and no further money was spent. The full written analysis, at $40,250, was contingent on them actually winning the bid. A capped bank of support hours sat in between for the fortnight of the final bid, so the deal team could get a question answered in hours rather than waiting on a report.
Why it matters
Diligence that arrives after the decision is an expense. This is what it looks like priced around the decision instead: the cheap, fast phase runs first and can stop everything, and the expensive phase only happens if there is a company to spend it on.
We do not provide legal opinions or legal clearance. This work is evidence-based technical assessment, built to support a buyer's commercial diligence and to inform their counsel.
More growth work
Capital raised and partners won
Protecting growth investment

Mid-eight-figure investment protected with a trade secret plan, a country-by-country patent strategy and transfer pricing support.
9 inventions captured, 9 applications filed, in 2 weeks, so a new product team could keep building.
Investors and acquirers
Boeing's venture fund. After early investment missteps, technology surveys that identified startups with complementary or superior technology.
Investment criteria, a diligence process sized to the fund, and a Series A preparation program for its portfolio companies.
A landscape of possible acquisitions, plus competitor analysis for litigation strategy.
The IP and evidence behind every result
4,000+ patentsSupported across 68 technology domains, for Adeia.
Invention to commercial dealsA full IP program built and run for Element3.
2 days, not monthsClaim charting with EVOS and one analyst.
EVOS gathers and organizes patents, market data and research; our people make the calls. Every finding traces back to a dated source you can check.
What our clients say
As we quickly commercialize our best ideas globally, Rapid Alpha continues to be an ideal business partner, brokering introductions with potential partners so we can immediately realize real commercial value.
Rapid Alpha's data-driven insights enabled us to drill down into the additional data the StrikeCo team needed to bring in investment, taking the hours of research required off the founding team's plates.
Rapid Alpha gave us deep and actionable insights for one of our key innovation projects, allowing us to make informed strategic decisions about the protection and commercialization of our intellectual property.
The team at Rapid Alpha delivered immediate returns on investment for us. They not only help us increase the value of our business through a comprehensive and affordable IP strategy, but they also help us take steps to negotiate from a position of strength.
What we won't put on this page
- No client name without written clearance.
- No testimonial nobody has signed off. Attribution requires sign-off, every time.
- No outcome claimed as ours when it was the client's. We state what we produced and let the causality stay conservative.
A proof page that overstates is worse than a thin one, because everything else on this site asks you to check the work.
Want the full case files?
We can share named case files, with the evidence behind each result, under NDA.







